News | August 06, 2024
SMS Pharmaceuticals reports Q1 FY25 consolidated PAT at Rs. 16.48 Cr
SMS Pharmaceuticals has reported total income of Rs. 165.81 crores during the quarter ended June 30, 2024
SMS Pharmaceuticals has reported total income of Rs. 165.81 crores during the quarter ended June 30, 2024
Strong topline growth driven by solid performance across key brands.
Fredun Pharmaceuticals has reported total income of Rs. 78.81 crores during the period ended June 30, 2024
Indoco Remedies is addressing the observations comprehensively and will respond to the USFDA within the stipulated timeframe
The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants
Leqselvi delivered statistically significant efficacy across two Phase 3 clinical trials
Torrent Pharmaceuticals has reported total income of Rs. 2,883 crores during the period ended June 30, 2024
Contepo offers a unique mechanism of action and has the potential to address increasing antibiotic resistance and gaps in the current antibiotic treatment landscape
Kwality Pharma already has registration of 20 molecules from the units and 20 are under registration
The company will address these observations within the stipulated timeline
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
